Ascletis Pharma (ASCLF) Stock Chart & Stock Price History $0.89 0.00 (0.00%) As of 05/29/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock Ascletis Pharma Stock Price Performance The Ascletis Pharma (ASCLF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 489.89%, with a year-to-date return of 273.21%. In the past month, the stock has increased 1.75%, reflecting recent market activity. As of the latest close, Ascletis Pharma traded at $0.89 with a market cap of and volume of 0 shares. Five years ago, the stock traded at $0.40, representing a 123.28% increase over that period. At the time, it had a market cap of and a volume of 10,000 shares. Receive ASCLF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascletis Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year PerformanceN/A5 Year Performance+123.28% ASCLF Stock Chart for Friday, May, 30, 2025 ASCLF Chart by TradingView Ascletis Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$0.89$0.89$0.89$0.89600 shs$0.0005/21/2025$0.85$0.89+5.34%$0.89$0.89600 shs$0.0005/12/2025$0.85$0.85$0.85$0.85800 shs$0.0005/09/2025$0.81$0.85+4.10%$0.85$0.85800 shs$0.0005/02/2025$0.81$0.81$0.81$0.81800 shs$0.0005/01/2025$0.88$0.81-7.21%$0.81$0.81800 shs$0.00 Related Companies 180 Life Sciences Stock Chart 3SBio Stock Chart 60 Degrees Pharmaceuticals Stock Chart Abcam Stock Chart Agentix Stock Chart Algernon Pharmaceuticals Stock Chart ALK-Abelló A/S Stock Chart Alpha Tau Medical Stock Chart Apollomics Stock Chart Arno Therapeutics Stock Chart Receive ASCLF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascletis Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ASCLF) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredUrgent: Make this trade before you hit your pillow tonight… Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascletis Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascletis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
